F-Prime Capital — 2024 Investments

1 investments dated 2024 · listed companies and verified rows first · show all

Zenflowzenflow.comin 𝕏Nov 2024

Zenflow develops medical devices for treating benign prostatic hyperplasia (BPH) in men, founded from the Stanford Byers Center for Biodesign with a team experienced in medical device development and FDA regulation.

HealthtechMedical DevicesSan Francisco, US

Shreya Mehta(Founder/CTO)inJohn Beck(Executive Officer)Nick Damiano(Executive Officer, Director)

BoardBryan Kim(Director)Robert Weisskoff(Director)Blayne Roeder(Director)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.